Ranitidine and Veramyst drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ranitidine (ranitidine) and Veramyst (fluticasone furoate). Common drug interactions include lactose intolerance among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Ranitidine and Veramyst. It is created by eHealthMe based on reports of 87 people who take the same drugs from the FDA, and is updated regularly.

What is Ranitidine?

Ranitidine has active ingredients of ranitidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 234,475 Ranitidine users. Check the latest studies of Ranitidine.

What is Veramyst?

Veramyst has active ingredients of fluticasone furoate. It is often used in allergies. eHealthMe is studying from 3,444 Veramyst users. Check the latest studies of Veramyst.

On Jul, 10, 2026

87 people who take Ranitidine and Veramyst together, and have interactions are studied.

Ranitidine and Veramyst drug interactions.

What are the common drug interactions of Ranitidine and Veramyst, by gender? *:

female:

Lactose intolerance (inability to digest lactose)
Post procedural swelling
Renal injury (kidney injury)
Renal tubular necrosis (death of kidney tubules)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Vomiting
Activities of daily living impaired
Anger
Autonomic nervous system imbalance (autonomic nervous system is of net equal emphasis)
Carbon dioxide decreased

male:

Chronic kidney disease
Nephrogenic anaemia (anaemia due to kidney disease)
Renal injury (kidney injury)
Abdominal pain
Anxiety
Application site urticaria
Blood potassium decreased
Blood testosterone decreased
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Cardiomyopathy (weakening of the heart muscle)

What are the common drug interactions of Ranitidine and Veramyst, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Dizziness
Fatigue (feeling of tiredness)
Lymphadenopathy (disease or enlargement of lymph nodes)
Nausea (feeling of having an urge to vomit)

20-29:

Hospitalisation
Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
Nasopharyngitis (inflammation of the nasopharynx)

30-39:

Abdominal pain upper
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Abdominal pain
Cholecystitis chronic (long lasting infection of gallbladder)
Gallbladder cholesterolosis (accumulation and deposition of cholesterol inside of the)
Post procedural bile leak
Chronic kidney disease
Activities of daily living impaired
Anger
Anxiety

40-49:

Chronic kidney disease
Renal failure (kidney dysfunction)
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Anxiety
Ataxia (loss of full control of bodily movements)
Balance disorder
Cerebellar atrophy (degeneration of the section of the brain responsible for balance, voluntary muscle movements)
Depression
Dysarthria (speech disorder)
Gait disturbance

50-59:

Exercise tolerance decreased
Food allergy
Gait disturbance
Hypophagia (reduced food intake)
Infusion related reaction
Infusion site haemorrhage (bleeding from infusion site)
Infusion site pruritus (severe itching at infusion site)
Injection site reaction
Left ventricular dysfunction
Mydriasis (a dilation of the pupil)

60+:

Chronic kidney disease
Nephrogenic anaemia (anaemia due to kidney disease)
Infection
Pain
Sneezing
Abdominal distension
Abdominal pain
Abscess limb (limb infection)
Anaemia (lack of blood)
Application site urticaria

What are the existing conditions these people have? *

Pain: 15 people, 17.24%
High Blood Pressure: 15 people, 17.24%
Hypersensitivity: 13 people, 14.94%
High Blood Cholesterol: 13 people, 14.94%
Multiple Myeloma (cancer of the plasma cells): 9 people, 10.34%
Stress And Anxiety: 8 people, 9.20%
Infection: 8 people, 9.20%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 8 people, 9.20%
Asthma: 8 people, 9.20%
Diabetes: 7 people, 8.05%

* Approximation only. Some reports may have incomplete information.

Do you take Ranitidine and Veramyst?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously